My take on the Rosacea trial is that they are going to use an increased cbd content up to 20% to see the safety profile. The Acne trial only used 5% and 10% in the 2b trial. If the 20% formulation has no safety issues they will use the 20% cbd formulation in the Acne phase 3 trial which will boost efficacy and have a clear separation from the vehicle. Anyone care to add to this?
BOT - Anything but charting, page-2220
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $624.4M | |||
| Open | High | Low | Value | Volume |
| 35.0¢ | 35.0¢ | 33.0¢ | $2.271M | 6.715M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 83805 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 112605 | 3 |
View Market Depth
| Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |